MedTrace Logo

Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients

NCT00641797 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2018-04-03

Study results available
· View outcomes & findings →

Summary

Benign Paroxysmal Positional Vertigo (BPPV) is a common complaint of emergency department patients. The importance of early diagnosis and treatment can lead to a much improved quality of life for patients afflicted by this ailment. It is the purpose of this study to evaluate and examine two methods of treatment. Patients will be randomized to receive the more common conventional medication therapy versus the canalith repositioning technique. All patients enrolled into this study are emergency department patients who have been diagnosed with BPPV via a positive Dix-Hallpike Maneuver. The hypothesis of this study is that vestibular rehabilitation will allow for resolution of symptoms without the use of conventional medication therapy in the acute management of BPPV in the emergency department patient.

Conditions

  • Benign Paroxysmal Positional Vertigo

Interventions

DRUG

Meclizine

medication administration 25mg PO one time

OTHER

Epley Maneuver

Patient has vestibular rehabilitation utilizing the Epley Maneuver.

DRUG

Lorazepam

Lorazepam 1 - 5mg PO/IV prn

DRUG

Diphenhydramine

25 - 50mg PO/IV once prn

DRUG

Ondansetron

Ondansetron 4 - 8 mg PO/IV prn

Sponsors & Collaborators

  • Lehigh Valley Hospital

    lead OTHER

Principal Investigators

  • David B. Burmeister, DO · Lehigh Valley Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2010-12-31
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00641797 on ClinicalTrials.gov